• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人源tau 病相关 tau 株决定了被招募用于模板扩增的底物。

Human tauopathy-derived tau strains determine the substrates recruited for templated amplification.

机构信息

Department of Brain and Neurosciences, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.

Laboratory of Neuropathology and Neuroscience, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo 113-0033, Japan.

出版信息

Brain. 2021 Sep 4;144(8):2333-2348. doi: 10.1093/brain/awab091.

DOI:10.1093/brain/awab091
PMID:33693528
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8418341/
Abstract

Tauopathies are a subset of neurodegenerative diseases characterized by abnormal tau inclusions. Specifically, three-repeat tau and four-repeat tau in Alzheimer's disease, three-repeat tau in Pick's disease (PiD) and four-repeat tau in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) form amyloid-like fibrous structures that accumulate in neurons and/or glial cells. Amplification and cell-to-cell transmission of abnormal tau based on the prion hypothesis are believed to explain the onset and progression of tauopathies. Recent studies support not only the self-propagation of abnormal tau, but also the presence of conformationally distinct tau aggregates, namely tau strains. Cryogenic electron microscopy analyses of patient-derived tau filaments have revealed disease-specific ordered tau structures. However, it remains unclear whether the ultrastructural and biochemical properties of tau strains are inherited during the amplification of abnormal tau in the brain. In this study, we investigated template-dependent amplification of tau aggregates using a cellular model of seeded aggregation. Tau strains extracted from human tauopathies caused strain-dependent accumulation of insoluble filamentous tau in SH-SY5Y cells. The seeding activity towards full-length four-repeat tau substrate was highest in CBD-tau seeds, followed by PSP-tau and Alzheimer's disease (AD)-tau seeds, while AD-tau seeds showed higher seeding activity than PiD-tau seeds towards three-repeat tau substrate. Abnormal tau amplified in cells inherited the ultrastructural and biochemical properties of the original seeds. These results strongly suggest that the structural differences of patient-derived tau strains underlie the diversity of tauopathies, and that seeded aggregation and filament formation mimicking the pathogenesis of sporadic tauopathy can be reproduced in cultured cells. Our results indicate that the disease-specific conformation of tau aggregates determines the tau isoform substrate that is recruited for templated amplification, and also influences the prion-like seeding activity.

摘要

tau 病是一类以 tau 异常包涵体为特征的神经退行性疾病。具体来说,阿尔茨海默病中的三重复 tau 和四重复 tau、匹克病(PiD)中的三重复 tau、进行性核上性麻痹(PSP)和皮质基底节变性(CBD)中的四重复 tau 形成类似淀粉样的纤维结构,在神经元和/或神经胶质细胞中积累。基于朊病毒假说的异常 tau 的扩增和细胞间传播被认为可以解释 tau 病的发病和进展。最近的研究不仅支持异常 tau 的自我传播,还支持存在构象不同的 tau 聚集物,即 tau 株。对源自患者的 tau 纤维的低温电子显微镜分析揭示了疾病特异性的有序 tau 结构。然而,在大脑中异常 tau 的扩增过程中,tau 株的超微结构和生化特性是否遗传仍不清楚。在这项研究中,我们使用种子聚集的细胞模型研究了 tau 聚集物的模板依赖性扩增。从人类 tau 病中提取的 tau 株导致可溶丝状 tau 在 SH-SY5Y 细胞中的株依赖性积累。在全长四重复 tau 底物中,CBD-tau 种子的引发活性最高,其次是 PSP-tau 和 AD-tau 种子,而 AD-tau 种子对三重复 tau 底物的引发活性高于 PiD-tau 种子。在细胞中扩增的异常 tau 继承了原始种子的超微结构和生化特性。这些结果强烈表明,源自患者的 tau 株的结构差异是 tau 病多样性的基础,并且可以在培养细胞中再现模拟散发性 tau 病发病机制的种子聚集和纤维形成。我们的结果表明,tau 聚集物的疾病特异性构象决定了被招募用于模板扩增的 tau 同工型底物,并且还影响类朊病毒的引发活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc08/8418341/3766358120bd/awab091f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc08/8418341/c99632a92a2c/awab091f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc08/8418341/70fa2ec69e5c/awab091f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc08/8418341/db012cd3589a/awab091f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc08/8418341/ca64fb99e60f/awab091f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc08/8418341/93a0577b2170/awab091f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc08/8418341/03f15268ac9f/awab091f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc08/8418341/15961668a468/awab091f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc08/8418341/3766358120bd/awab091f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc08/8418341/c99632a92a2c/awab091f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc08/8418341/70fa2ec69e5c/awab091f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc08/8418341/db012cd3589a/awab091f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc08/8418341/ca64fb99e60f/awab091f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc08/8418341/93a0577b2170/awab091f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc08/8418341/03f15268ac9f/awab091f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc08/8418341/15961668a468/awab091f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc08/8418341/3766358120bd/awab091f8.jpg

相似文献

1
Human tauopathy-derived tau strains determine the substrates recruited for templated amplification.人源tau 病相关 tau 株决定了被招募用于模板扩增的底物。
Brain. 2021 Sep 4;144(8):2333-2348. doi: 10.1093/brain/awab091.
2
Pathological Tau Strains from Human Brains Recapitulate the Diversity of Tauopathies in Nontransgenic Mouse Brain.来自人类大脑的病理性 Tau 蛋白菌株概括了非转基因小鼠大脑中 Tau 蛋白病的多样性。
J Neurosci. 2017 Nov 22;37(47):11406-11423. doi: 10.1523/JNEUROSCI.1230-17.2017. Epub 2017 Oct 20.
3
Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies.散发性tau蛋白病中tau蛋白的细胞病理学及tau蛋白异构体的免疫组织化学研究
Neuropathology. 2006 Oct;26(5):457-70. doi: 10.1111/j.1440-1789.2006.00743.x.
4
[Neuropathology of tauopathy].[tau蛋白病的神经病理学]
Brain Nerve. 2013 Dec;65(12):1445-58.
5
Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.使用新型构象选择性 Tau 抗体通过免疫组织化学检测 AD 和非 AD Tau 病中的 AD 特异性 Tau 病理学。
J Neuropathol Exp Neurol. 2018 Mar 1;77(3):216-228. doi: 10.1093/jnen/nly010.
6
Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation.新型人神经元 tau 模型,表现出神经纤维缠结和细胞间传播。
Neurobiol Dis. 2017 Oct;106:222-234. doi: 10.1016/j.nbd.2017.06.005. Epub 2017 Jun 10.
7
Tau exhibits unique seeding properties in globular glial tauopathy.Tau 在球形神经胶质朊病毒病中表现出独特的成核特性。
Acta Neuropathol Commun. 2019 Mar 7;7(1):36. doi: 10.1186/s40478-019-0691-9.
8
Structure of NFT: Biochemical Approach.NFT 的结构:生化方法。
Adv Exp Med Biol. 2019;1184:23-34. doi: 10.1007/978-981-32-9358-8_2.
9
Tau Fibril Formation in Cultured Cells Compatible with a Mouse Model of Tauopathy.在与 Tau 病小鼠模型兼容的培养细胞中形成 Tau 纤维。
Int J Mol Sci. 2018 May 17;19(5):1497. doi: 10.3390/ijms19051497.
10
In vitro amplification of pathogenic tau conserves disease-specific bioactive characteristics.在体外扩增致病的 tau 蛋白可以保留疾病特异性的生物活性特征。
Acta Neuropathol. 2021 Feb;141(2):193-215. doi: 10.1007/s00401-020-02253-4. Epub 2021 Jan 1.

引用本文的文献

1
Repositioning of polyubiquitin alters the pathologic tau filament structure.多聚泛素的重新定位改变了病理性tau蛋白丝结构。
bioRxiv. 2025 May 8:2025.05.02.651930. doi: 10.1101/2025.05.02.651930.
2
Probe-dependent Proximity Profiling (ProPPr) Uncovers Similarities and Differences in Phospho-Tau-Associated Proteomes Between Tauopathies.基于探针的邻近分析(ProPPr)揭示了tau蛋白病之间磷酸化tau相关蛋白质组的异同。
Mol Neurodegener. 2025 Mar 13;20(1):32. doi: 10.1186/s13024-025-00817-0.
3
Sensitive detection and propagation of brain-derived tau assemblies in HEK293-based wild-type tau seeding assays.
基于HEK293的野生型tau种子检测法中脑源性tau聚集体的灵敏检测与传播
J Biol Chem. 2025 Mar;301(3):108245. doi: 10.1016/j.jbc.2025.108245. Epub 2025 Jan 27.
4
Loss of calcium/calmodulin-dependent protein kinase kinase 2, transferrin, and transferrin receptor proteins in the temporal cortex of Alzheimer's patients postmortem is associated with abnormal iron homeostasis: implications for patient survival.阿尔茨海默病患者死后颞叶皮质中钙/钙调蛋白依赖性蛋白激酶激酶2、转铁蛋白和转铁蛋白受体蛋白的缺失与铁稳态异常有关:对患者生存的影响。
Front Cell Dev Biol. 2024 Nov 28;12:1469751. doi: 10.3389/fcell.2024.1469751. eCollection 2024.
5
Diagnosing primary lateral sclerosis: a clinico-pathological study.原发性侧索硬化症的诊断:一项临床病理研究。
J Neurol. 2024 Dec 12;272(1):46. doi: 10.1007/s00415-024-12816-0.
6
Targeted protein degradation with bifunctional molecules as a novel therapeutic modality for Alzheimer's disease & beyond.以双功能分子进行靶向蛋白质降解作为治疗阿尔茨海默病及其他疾病的新型治疗方式。
Neurotherapeutics. 2025 Apr;22(3):e00499. doi: 10.1016/j.neurot.2024.e00499. Epub 2024 Dec 4.
7
Post-Translational Modifications Control Phase Transitions of Tau.翻译后修饰调控Tau蛋白的相变
ACS Cent Sci. 2024 Nov 13;10(11):2145-2161. doi: 10.1021/acscentsci.4c01319. eCollection 2024 Nov 27.
8
The cellular prion protein does not affect tau seeding and spreading of sarkosyl-insoluble fractions from Alzheimer's disease.细胞朊蛋白不影响阿尔茨海默病中十二烷基肌氨酸不溶部分的tau蛋白种子形成和扩散。
Sci Rep. 2024 Sep 16;14(1):21622. doi: 10.1038/s41598-024-72232-2.
9
Co-opting templated aggregation to degrade pathogenic tau assemblies and improve motor function.利用模板化聚集物来降解致病的 tau 聚集体并改善运动功能。
Cell. 2024 Oct 17;187(21):5967-5980.e17. doi: 10.1016/j.cell.2024.08.024. Epub 2024 Sep 13.
10
Precision proteoform design for 4R tau isoform selective templated aggregation.针对 4R tau 异构体选择性模板聚集进行精准的蛋白构象设计。
Proc Natl Acad Sci U S A. 2024 Apr 9;121(15):e2320456121. doi: 10.1073/pnas.2320456121. Epub 2024 Apr 3.